MannKind CorporationMNKD stock score: 56/100

$3.95 · -2.95% · Scored Nov 19, 2026

Technical
43
Fundamental
59
News
52

The reading

MannKind (MNKD) scores 56 out of 100, which reads neutral, higher than 64% of Healthcare stocks and 63% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 59, technicals 43.

Among the fundamentals, Price Target at 100 and Revenue Growth (5-Year) at 97 score highest, while Earnings Quality (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 56 and contrarian oscillators 42.

News sentiment is neutral at 52; it is shown, not counted in the composite.

Since Aug 23, 2026 the composite has ranged from 37 to 58, and it is up 9 points over the period.

About MannKind

MannKind (MNKD) is a biopharmaceutical company that develops and makes inhaled therapies and other treatments for endocrine and cardiopulmonary diseases. Its Technosphere dry-powder inhalation platform is the basis for Afrezza, an inhaled mealtime insulin approved for adults with diabetes and more recently for children, which MannKind sells in the United States. It also makes Tyvaso DPI, an inhaled form of treprostinil for pulmonary hypertension, for United Therapeutics, earning manufacturing revenue and royalties on its sales. Through its acquisition of scPharmaceuticals, MannKind sells FUROSCIX, a furosemide treatment given under the skin at home to relieve fluid buildup in patients with heart failure or chronic kidney disease. Its pipeline includes inhaled versions of nintedanib for idiopathic pulmonary fibrosis and other lung diseases. MannKind earns money from product sales, royalties and contract manufacturing.

MannKind competes with Novo Nordisk, Eli Lilly and Sanofi in insulin, while Tyvaso DPI competes with Liquidia’s Yutrepia and other pulmonary hypertension drugs, and FUROSCIX competes mainly with hospital and oral diuretic treatment. Its edge rests on proprietary inhalation technology, manufacturing capability and a royalty stream that supports its own launches. Investors who follow MNKD stock tend to watch Tyvaso DPI royalties and FUROSCIX sales growth. Afrezza adoption, including in children, is closely followed. Pipeline data, operating costs and debt levels are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward MNKD’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

59

Pulling it up

Holding it back

35 weighted scorers; 4 had no data today and are left out rather than counted as zero.

Technical · daily

55

Pulling it up

  • Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • Performance versus SPY compares the stock's returns to the S&P 500 index.

  • Know Sure Thing (KST) combines multiple rate-of-change calculations to identify long-term trend reversals.

Holding it back

  • SPY SMA 20 measures the S&P 500 (SPY) position relative to its 20-period moving average.

  • Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • SPY SMA 50 tracks the S&P 500 (SPY) position relative to its 50-period moving average.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
52

Technical score by timeframe

ChartScoreWeight
Hourly381
Daily553
Weekly422
Monthly342
Quarterly372

Composite score, last 90 days

05010056Aug 23, 2026Nov 19, 2026Aug 23, 2026: 47Aug 24, 2026: 46Aug 25, 2026: 47Aug 26, 2026: 46Aug 27, 2026: 44Aug 28, 2026: 42Aug 29, 2026: 43Aug 30, 2026: 43Aug 31, 2026: 43Sep 1, 2026: 44Sep 2, 2026: 45Sep 3, 2026: 43Sep 4, 2026: 43Sep 5, 2026: 44Sep 6, 2026: 44Sep 7, 2026: 44Sep 8, 2026: 47Sep 9, 2026: 44Sep 10, 2026: 41Sep 11, 2026: 41Sep 12, 2026: 41Sep 13, 2026: 41Sep 14, 2026: 41Sep 15, 2026: 38Sep 16, 2026: 38Sep 17, 2026: 39Sep 18, 2026: 39Sep 19, 2026: 39Sep 20, 2026: 39Sep 21, 2026: 40Sep 22, 2026: 39Sep 23, 2026: 39Sep 24, 2026: 39Sep 25, 2026: 39Sep 26, 2026: 39Sep 27, 2026: 39Sep 28, 2026: 39Sep 29, 2026: 39Sep 30, 2026: 44Oct 1, 2026: 46Oct 2, 2026: 44Oct 3, 2026: 45Oct 4, 2026: 45Oct 5, 2026: 43Oct 6, 2026: 43Oct 7, 2026: 39Oct 8, 2026: 38Oct 9, 2026: 38Oct 10, 2026: 38Oct 11, 2026: 38Oct 12, 2026: 38Oct 13, 2026: 37Oct 14, 2026: 38Oct 15, 2026: 39Oct 16, 2026: 37Oct 17, 2026: 38Oct 18, 2026: 38Oct 19, 2026: 38Oct 20, 2026: 38Oct 21, 2026: 38Oct 22, 2026: 39Oct 23, 2026: 39Oct 24, 2026: 40Oct 25, 2026: 40Oct 26, 2026: 40Oct 27, 2026: 40Oct 28, 2026: 41Oct 29, 2026: 42Oct 30, 2026: 42Nov 1, 2026: 42Nov 2, 2026: 44Nov 3, 2026: 45Nov 4, 2026: 47Nov 5, 2026: 42Nov 6, 2026: 45Nov 7, 2026: 47Nov 8, 2026: 46Nov 10, 2026: 49Nov 11, 2026: 48Nov 12, 2026: 58Nov 13, 2026: 57Nov 14, 2026: 57Nov 15, 2026: 57Nov 16, 2026: 56Nov 17, 2026: 57Nov 18, 2026: 57Nov 19, 2026: 56
Show the daily numbers
DateComposite
Nov 19, 202656
Nov 18, 202657
Nov 17, 202657
Nov 16, 202656
Nov 15, 202657
Nov 14, 202657
Nov 13, 202657
Nov 12, 202658
Nov 11, 202648
Nov 10, 202649
Nov 8, 202646
Nov 7, 202647
Nov 6, 202645
Nov 5, 202642
Nov 4, 202647
Nov 3, 202645
Nov 2, 202644
Nov 1, 202642
Oct 30, 202642
Oct 29, 202642
Oct 28, 202641
Oct 27, 202640
Oct 26, 202640
Oct 25, 202640
Oct 24, 202640
Oct 23, 202639
Oct 22, 202639
Oct 21, 202638
Oct 20, 202638
Oct 19, 202638
Oct 18, 202638
Oct 17, 202638
Oct 16, 202637
Oct 15, 202639
Oct 14, 202638
Oct 13, 202637
Oct 12, 202638
Oct 11, 202638
Oct 10, 202638
Oct 9, 202638
Oct 8, 202638
Oct 7, 202639
Oct 6, 202643
Oct 5, 202643
Oct 4, 202645
Oct 3, 202645
Oct 2, 202644
Oct 1, 202646
Sep 30, 202644
Sep 29, 202639
Sep 28, 202639
Sep 27, 202639
Sep 26, 202639
Sep 25, 202639
Sep 24, 202639
Sep 23, 202639
Sep 22, 202639
Sep 21, 202640
Sep 20, 202639
Sep 19, 202639
Sep 18, 202639
Sep 17, 202639
Sep 16, 202638
Sep 15, 202638
Sep 14, 202641
Sep 13, 202641
Sep 12, 202641
Sep 11, 202641
Sep 10, 202641
Sep 9, 202644
Sep 8, 202647
Sep 7, 202644
Sep 6, 202644
Sep 5, 202644
Sep 4, 202643
Sep 3, 202643
Sep 2, 202645
Sep 1, 202644
Aug 31, 202643
Aug 30, 202643
Aug 29, 202643
Aug 28, 202642
Aug 27, 202644
Aug 26, 202646
Aug 25, 202647
Aug 24, 202646
Aug 23, 202647

Key facts

Market cap
$1.3B
Sector
Healthcare
Industry
Biotechnology
Beta
1.09
Risk grade (1–10)
3
Next earnings
Nov 5, 2026

Questions

What is MNKD's stock rating today?

MNKD scores 56/100 (Neutral) as of Nov 19, 2026: technical 43, fundamental 59, and news sentiment 52, which is shown but not counted. Scores are recomputed every night.

What does MannKind do?

MannKind (MNKD) is a biopharmaceutical company that develops and makes inhaled therapies and other treatments for endocrine and cardiopulmonary diseases. Its Technosphere dry-powder inhalation platform is the basis for Afrezza, an inhaled mealtime insulin approved for adults with diabetes and more recently for children, which MannKind sells in the United States.

Is MNKD stock a buy?

The score is not a buy or sell recommendation. A 56 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the MNKD score calculated?

97 weighted scorers feed it today: 35 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

MNKD stock score

HTML

<a href="https://stocksscores.com/stocks/mnkd/"><img src="https://stocksscores.com/stocks/mnkd/badge.svg" alt="MNKD stock score" height="20"></a>

Markdown

[![MNKD stock score](https://stocksscores.com/stocks/mnkd/badge.svg)](https://stocksscores.com/stocks/mnkd/)